Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher P Day

Showing results (1-10 of 121) with videos related to

Pageof 13
Sort By:
Clinical Medicine (London, England)|April 30, 2011
Non-alcoholic fatty liver disease: a massive problemChristopher P Day
The American Journal of Gastroenterology|August 23, 2002
NASH-related liver failure: one hit too many?Christopher P Day
Hepatology (Baltimore, Md.)|September 10, 2010
Liver enzymes, nonalcoholic fatty liver disease, and incident cardiovascular diseaseGiovanni Targher, Christopher P Day
Nature Clinical Practice. Gastroenterology & Hepatology|January 5, 2007
Management strategies in alcoholic liver diseaseHerbert Tilg, Christopher P Day
Clinics in Liver Disease|August 29, 2007
Nonsteroidal anti-inflammatory drug-induced hepatotoxicityGuruprasad P Aithal, Christopher P Day
Journal of Hepatology|February 20, 2003
The management of alcoholic liver diseaseStephen F Stewart, Christopher P Day
Drug Metabolism Reviews|September 15, 2011
Genetic association studies in drug-induced liver injuryAnn K Daly, Christopher P Day
Journal of Hepatology|June 5, 2012
S-adenosylmethionine (SAMe) therapy in liver disease: a review of current evidence and clinical utilityQuentin M Anstee, Christopher P Day
Nature Reviews. Gastroenterology & Hepatology|September 25, 2013
The genetics of NAFLDQuentin M Anstee, Christopher P Day
Seminars in Liver Disease|September 18, 2015
Foreword. Nonalcoholic Fatty Liver DiseaseChristopher P Day, Quentin M Anstee
Pageof 13

Showing results (1-10 of 121) with videos related to

Sort By:
Pageof 13
Clinical Medicine (London, England)|April 30, 2011
Non-alcoholic fatty liver disease: a massive problemChristopher P Day
The American Journal of Gastroenterology|August 23, 2002
NASH-related liver failure: one hit too many?Christopher P Day
Hepatology (Baltimore, Md.)|September 10, 2010
Liver enzymes, nonalcoholic fatty liver disease, and incident cardiovascular diseaseGiovanni Targher, Christopher P Day
Nature Clinical Practice. Gastroenterology & Hepatology|January 5, 2007
Management strategies in alcoholic liver diseaseHerbert Tilg, Christopher P Day
Clinics in Liver Disease|August 29, 2007
Nonsteroidal anti-inflammatory drug-induced hepatotoxicityGuruprasad P Aithal, Christopher P Day
Journal of Hepatology|February 20, 2003
The management of alcoholic liver diseaseStephen F Stewart, Christopher P Day
Drug Metabolism Reviews|September 15, 2011
Genetic association studies in drug-induced liver injuryAnn K Daly, Christopher P Day
Journal of Hepatology|June 5, 2012
S-adenosylmethionine (SAMe) therapy in liver disease: a review of current evidence and clinical utilityQuentin M Anstee, Christopher P Day
Nature Reviews. Gastroenterology & Hepatology|September 25, 2013
The genetics of NAFLDQuentin M Anstee, Christopher P Day
Seminars in Liver Disease|September 18, 2015
Foreword. Nonalcoholic Fatty Liver DiseaseChristopher P Day, Quentin M Anstee
Pageof 13